[{"address1": "2222 Ponce de Leon Blvd.", "address2": "Floor 3", "city": "Coral Gables", "state": "FL", "zip": "33134", "country": "United States", "phone": "786 629 1376", "website": "https://www.relmada.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. It also develops REL-P11, a modified-release formulation of psilocybin that has completed Phase 1 safety study for the treatment of metabolic disease. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.", "fullTimeEmployees": 17, "companyOfficers": [{"maxAge": 1, "name": "Dr. Sergio  Traversa M.B.A., Pharm.D.", "age": 65, "title": "CEO & Director", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 1800723, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Maged S. Shenouda M.B.A., R.Ph.", "age": 61, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 993750, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul E. Kelly M.B.A.", "age": 68, "title": "COO & Director", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 872780, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Charles S. Ence CPA, M.B.A.", "age": 60, "title": "Chief Accounting & Compliance Officer", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 983039, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Gina  DiGuglielmo", "title": "VP & Head of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raj S. Pruthi F.A.C.S., M.D., M.H.A.", "age": 58, "title": "Chief Medical Officer of Urology", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew  Cutler", "title": "Senior Clinical Development Advisor", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Richard M. Mangano Ph.D.", "age": 75, "title": "Consultant", "yearBorn": 1950, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 10, "compensationRisk": 10, "shareHolderRightsRisk": 5, "overallRisk": 9, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.8, "open": 3.8, "dayLow": 3.66, "dayHigh": 3.8, "regularMarketPreviousClose": 3.8, "regularMarketOpen": 3.8, "regularMarketDayLow": 3.66, "regularMarketDayHigh": 3.8, "payoutRatio": 0.0, "beta": 0.775, "forwardPE": -10.388888, "volume": 540618, "regularMarketVolume": 540618, "averageVolume": 1171450, "averageVolume10days": 481400, "averageDailyVolume10Day": 481400, "bid": 3.68, "ask": 3.79, "bidSize": 5, "askSize": 5, "marketCap": 274267744, "fiftyTwoWeekLow": 0.24, "fiftyTwoWeekHigh": 5.12, "allTimeHigh": 80.0, "allTimeLow": 0.24, "fiftyDayAverage": 4.0876, "twoHundredDayAverage": 1.763355, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 260381216, "profitMargins": 0.0, "floatShares": 65409924, "sharesOutstanding": 73333622, "sharesShort": 1388226, "sharesShortPriorMonth": 772889, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.0189, "heldPercentInsiders": 0.10751, "heldPercentInstitutions": 0.1868, "shortRatio": 1.39, "shortPercentOfFloat": 0.0191, "impliedSharesOutstanding": 73333622, "bookValue": 0.285, "priceToBook": 13.1228075, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -56174540, "trailingEps": -1.78, "forwardEps": -0.36, "lastSplitFactor": "1:4", "lastSplitDate": 1569801600, "52WeekChange": 9.080863, "SandP52WeekChange": 0.14725316, "quoteType": "EQUITY", "currentPrice": 3.74, "targetHighPrice": 10.0, "targetLowPrice": 1.0, "targetMeanPrice": 6.66667, "targetMedianPrice": 9.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 13886524, "totalCashPerShare": 0.189, "totalDebt": 0, "quickRatio": 2.676, "currentRatio": 2.862, "returnOnAssets": -1.02412, "returnOnEquity": -1.9678999, "freeCashflow": -20166900, "operatingCashflow": -39990400, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "RLMD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Relmada Therapeutics, Inc.", "longName": "Relmada Therapeutics, Inc.", "corporateActions": [], "postMarketTime": 1768608565, "regularMarketTime": 1768597200, "exchange": "NCM", "messageBoardId": "finmb_9070579", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.57895, "regularMarketPrice": 3.74, "marketState": "CLOSED", "priceEpsCurrentYear": -4.5060244, "fiftyDayAverageChange": -0.34760022, "fiftyDayAverageChangePercent": -0.08503772, "twoHundredDayAverageChange": 1.976645, "twoHundredDayAverageChangePercent": 1.1209569, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1403271000000, "postMarketChangePercent": -1.0721952, "postMarketPrice": 3.6999, "postMarketChange": -0.040100098, "regularMarketChange": -0.0599999, "regularMarketDayRange": "3.66 - 3.8", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1171450, "fiftyTwoWeekLowChange": 3.5, "fiftyTwoWeekLowChangePercent": 14.583334, "fiftyTwoWeekRange": "0.24 - 5.12", "fiftyTwoWeekHighChange": -1.3799999, "fiftyTwoWeekHighChangePercent": -0.26953122, "fiftyTwoWeekChangePercent": 908.0863, "dividendDate": 1569801600, "earningsTimestamp": 1763067600, "earningsTimestampStart": 1763067600, "earningsTimestampEnd": 1763067600, "earningsCallTimestampStart": 1763069400, "earningsCallTimestampEnd": 1763069400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.78, "epsForward": -0.36, "epsCurrentYear": -0.83, "displayName": "Relmada Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-17"}]